Literature DB >> 33495479

Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.

Hanna Tomczak1,2, Marcin Gabryel3, Oliwia Zakerska-Banaszak4, Alina Baturo3, Lukasz Wolko5, Michal Michalak6, Natalia Malinska1, Dorota Mankowska-Wierzbicka3, Piotr Eder3, Agnieszka Dobrowolska3, Ryszard Slomski7, Marzena Skrzypczak-Zielinska7.   

Abstract

Ulcerative colitis (UC) is a chronic immune-mediated disorder, whose etiology is not fully understood and for which no effective treatment is available. Recently, research has focused on the dysbiosis of gut microbiome in UC. However, the results so far remain inconsistent and insufficient to understand the microbial component in UC pathogenesis. In this study, we determine specific changes in the gut microbial profile in Polish UC patients compared to healthy subjects for the first time. Using 16S rRNA gene-based analysis we have described the intestinal microbial community in a group of 20 individuals (10 UC patients and 10 controls). Our results after multiple hypothesis testing correction demonstrated substantially lower gut microbiome diversity in UC cases compared to the controls and considerable differences at the phylum level, as well as among 13 bacterial families and 20 bacterial genera (p < 0.05). UC samples were more abundant in Proteobacteria (8.42%), Actinobacteria (6.89%) and Candidate Division TM7 (2.88%) than those of healthy volunteers (2.57%, 2.29% and 0.012%, respectively). On the other hand, Bacteroidetes and Verrucomicrobia were presented at a lower level in UC relative to the controls (14% and 0% vs 27.97% and 4.47%, respectively). In conclusion, our results show a reduced gut microbial diversity in Polish UC patients, a reduction of taxa with an anti-inflammatory impact and an increased abundance of potentially pathogenic bacteria.

Entities:  

Year:  2021        PMID: 33495479      PMCID: PMC7835370          DOI: 10.1038/s41598-021-81628-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  51 in total

Review 1.  Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.

Authors:  Jolanda M van Dieren; Ernst J Kuipers; Janneke N Samsom; Edward E Nieuwenhuis; C Janneke van der Woude
Journal:  Inflamm Bowel Dis       Date:  2006-04       Impact factor: 5.325

Review 2.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

3.  Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice.

Authors:  Myung H Kim; Seung G Kang; Jeong H Park; Masashi Yanagisawa; Chang H Kim
Journal:  Gastroenterology       Date:  2013-05-07       Impact factor: 22.682

Review 4.  Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.

Authors:  S G Nugent; D Kumar; D S Rampton; D F Evans
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.

Authors:  Rapat Pittayanon; Jennifer T Lau; Grigorios I Leontiadis; Frances Tse; Yuhong Yuan; Michael Surette; Paul Moayyedi
Journal:  Gastroenterology       Date:  2019-12-05       Impact factor: 22.682

6.  Environmental risk factors for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

7.  Structure, function and diversity of the healthy human microbiome.

Authors: 
Journal:  Nature       Date:  2012-06-13       Impact factor: 49.962

8.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.

Authors:  Alan W Walker; Jeremy D Sanderson; Carol Churcher; Gareth C Parkes; Barry N Hudspith; Neil Rayment; Jonathan Brostoff; Julian Parkhill; Gordon Dougan; Liljana Petrovska
Journal:  BMC Microbiol       Date:  2011-01-10       Impact factor: 3.605

Review 9.  The gut microbiota in mouse models of inflammatory bowel disease.

Authors:  Kalliopi K Gkouskou; Chrysoula Deligianni; Christos Tsatsanis; Aristides G Eliopoulos
Journal:  Front Cell Infect Microbiol       Date:  2014-02-28       Impact factor: 5.293

10.  Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.

Authors:  Adam G Clooney; Julia Eckenberger; Emilio Laserna-Mendieta; Kathryn A Sexton; Matthew T Bernstein; Kathy Vagianos; Michael Sargent; Feargal J Ryan; Carthage Moran; Donal Sheehan; Roy D Sleator; Laura E Targownik; Charles N Bernstein; Fergus Shanahan; Marcus J Claesson
Journal:  Gut       Date:  2020-06-14       Impact factor: 23.059

View more
  15 in total

Review 1.  Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease.

Authors:  Sabrina Naud; Ahmad Ibrahim; Camille Valles; Mohamad Maatouk; Fadi Bittar; Maryam Tidjani Alou; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2022-06-06       Impact factor: 50.129

Review 2.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

3.  Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Petra Adamkova; Petra Hradicka; Helena Kupcova Skalnikova; Veronika Cizkova; Petr Vodicka; Silvia Farkasova Iannaccone; Monika Kassayova; Sona Gancarcikova; Vlasta Demeckova
Journal:  Vet Sci       Date:  2022-05-16

4.  Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis.

Authors:  Natalia Molinero; Diego Taladrid; Irene Zorraquín-Peña; Miguel de Celis; Ignacio Belda; Alex Mira; Begoña Bartolomé; M Victoria Moreno-Arribas
Journal:  Curr Issues Mol Biol       Date:  2022-03-30       Impact factor: 2.976

Review 5.  The Communication Between Intestinal Microbiota and Ulcerative Colitis: An Exploration of Pathogenesis, Animal Models, and Potential Therapeutic Strategies.

Authors:  Yu Hu; Zhen Ye; Mingquan Wu; Yingqi She; Linzhen Li; Yujie Xu; Kaihua Qin; Zhipeng Hu; Maoyi Yang; Fating Lu; Qiaobo Ye
Journal:  Front Med (Lausanne)       Date:  2021-12-13

6.  In Vivo Healthy Benefits of Galacto-Oligosaccharides from Lupinus albus (LA-GOS) in Butyrate Production through Intestinal Microbiota.

Authors:  Lucila A Godínez-Méndez; Carmen M Gurrola-Díaz; José Sergio Zepeda-Nuño; Natali Vega-Magaña; Rocio Ivette Lopez-Roa; Liliana Íñiguez-Gutiérrez; Pedro M García-López; Mary Fafutis-Morris; Vidal Delgado-Rizo
Journal:  Biomolecules       Date:  2021-11-09

Review 7.  Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota-Gut-Brain Axis.

Authors:  Elena Layunta; Berta Buey; Jose Emilio Mesonero; Eva Latorre
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-08       Impact factor: 5.555

8.  Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile.

Authors:  Hao-Ming Xu; Hong-Li Huang; Yan-Di Liu; Jia-Qi Zhu; You-Lian Zhou; Hui-Ting Chen; Jing Xu; Hai-Lan Zhao; Xue Guo; Wei Shi; Yu-Qiang Nie; Yong-Jian Zhou
Journal:  BMC Microbiol       Date:  2021-10-16       Impact factor: 3.605

9.  Substantial Intestinal Microbiota Differences Between Patients With Ulcerative Colitis From Ghana and Denmark.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Katleen Vranckx; Henrik Vedel Nielsen; Lee O'Brien Andersen; Timothy Archampong; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Front Cell Infect Microbiol       Date:  2022-03-03       Impact factor: 5.293

10.  Dietary Alaska Pollock Protein Attenuates the Experimental Colitis Induced by Dextran Sulfate Sodium via Regulation of Gut Microbiota and Its Metabolites in Mice.

Authors:  Genki Tanaka; Nozomi Hagihara; Ryota Hosomi; Takaki Shimono; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida; Kenji Fukunaga
Journal:  Metabolites       Date:  2022-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.